A*STAR Genome Institute of Singapore (A*STAR GIS)

A new cellular model of colorectal cancer helps identify high-risk subtypes likely to resist standard treatments and proliferate in response.

Nanopore sequencing and a self-enhancing AI model team up to enable a faster and more accurate method for reading synthetic genes.

As the Chairman of Singapore’s lead R&D public sector agency, Chorh Chuan Tan outlines A*STAR’s strategic role within a new phase of national strategic priorities in research, innovation and enterprise.

At A*STAR, precision medicine and population health are bridging disciplines to shed new light on facets of human development and well-being, enabling targeted early interventions to enhance the healthspans of Asian populations.

This year’s L’Oréal-UNESCO For Women in Science (Singapore) Awards programme recognises three women scientists for their exceptional contributions to neuroscience, infectious diseases and RNA therapeutics.

A unique RNA structure shared across SARS-CoV-2 variants may contribute to viral fitness, offering a potential target for new antiviral treatments.

Comparing hypothalamic networks in zebrafish and mice reveals evolutionarily conserved neuronal pathways that regulate appetite across vertebrates.

Enhanced RNA-based profiling techniques reveal the outsized metabolic impacts of small microbial populations across the human body surface.

The largest RNA language model to date helps researchers uncover the hidden roles played by non-coding RNA sequences in our cells.

City-wide surveillance establishes baseline microbiome data for Singapore’s food centres, revealing stable microbial communities unique to each site.

Self-looping molecules could be the key to unlocking the potential of RNA-based vaccines and therapies.

A new precision oncology platform taps into machine learning to guide colorectal cancer treatments based on individual genetics.